Visibility Score
46/100
AI Mentions
143
AI Search Volume
48.0K
As of June 25, 2026, AngioDynamics (angiodynamics.com) has an AI visibility score of 46 out of 100, based on 143 total AI mentions across platforms like Google AI Overview and ChatGPT. The brand generates 48.0K AI search volume. Compared to peers in the life sciences sector, AngioDynamics ranks #7 of 7 in AI mention share of voice.
AngioDynamics is a US-based medical device company in the Cardiovascular segment, registered with the U.S. FDA. This report tracks how AngioDynamics appears in AI search — ChatGPT, Google AI Overview and other answer engines.
AI Visibility Breakdown
AngioDynamics has 143 total AI mentions across 2 tracked platforms, generating 48.0K in AI search volume. Google AI Overview accounts for the largest share at 97% of mentions.
By Platform
Brand Entities
No brand entity data available.
Where AI Sources Its Answers About AngioDynamics
When AI assistants answer questions involving AngioDynamics, these are the domains they most often cite. Winning AI visibility means being present and referenced on the sources the model actually reads — which is rarely a company's own website.
Share of Voice vs Competitors
AngioDynamics ranks #7 out of 7 competitors in AI mention share of voice, capturing 2% of total mentions. Boston Scientific leads with 5.3K AI mentions. Competitors tracked include Boston Scientific, Edwards Lifesciences, Merit Medical, Biotronik.
AI Mentions
Comparison
| Company | Mentions | AI Vol |
|---|---|---|
| angiodynamics.com (You) | 143 | 48.0K |
| bostonscientific.com (Boston Scientific) | 5.3K | 2.9M |
| edwards.com (Edwards Lifesciences) | 844 | 362.8K |
| merit.com (Merit Medical) | 420 | 213.2K |
| biotronik.com (Biotronik) | 303 | 271.3K |
| livanova.com (LivaNova) | 219 | 266.3K |
| terumo.com (Terumo) | 195 | 48.6K |
Improve your brand's AI visibility
This is a static snapshot. VayoMed helps life sciences brands monitor AI mentions, track competitors, and build the content and citation signals that make AI platforms more likely to recommend them.